Literature DB >> 23312770

Predictors of success in smoking cessation among Italian adults motivated to quit.

Paolo Iliceto1, Emanuele Fino, Stefania Pasquariello, Maria E D'Angelo Di Paola, Domenico Enea.   

Abstract

We examined the role of sexual gender, age, working status, education, cigarettes per day, Fagerström test, age of onset, pharmacologic intervention (bupropion or varenicline), 10 sessions of cognitive-behavioral group counseling therapy (GCT) conducted over 6 weeks, and level of attendance of the counseling program as predictors of smoking cessation on 1282 Italian adult smokers. Results of a multi-variate forward stepwise conditional logistic analysis, at the first step, indicate that subjects who attended the program from 4 to 6 sessions and from 1 to 3 sessions, respectively, resulted about 3 times and 24 times more likely to smoke than those attending from 7 to 10 sessions; at the second step, subjects with high Fagerström score were 2 times more likely to smoke than subjects with low/middle Fagerström; at the third step, subjects treated only with GCT were 2 times more likely to smoke than subjects with combined pharmacologic interventions and GCT; at the fourth step, subjects with age of onset less than 17 years were 1.5 times more likely to smoke than subjects with a higher age of onset; eventually, at the fifth step women resulted 1.5 times more likely to smoke than men. In conclusion, we found that a steady attendance of the cognitive behavioral program, as well as the addition of pharmacologic interventions to counseling, remarkably increased the probability of the smoking cessation behavior to be determined. Nevertheless, FTQ was a valid measure in predicting the smoking cessation, and women revealed to be more likely to keep the smoking behavior, as well as subjects who declared an age of onset less than 17 years.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312770     DOI: 10.1016/j.jsat.2012.12.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  6 in total

1.  Factor structure and psychometric properties of the Italian version of the Gambling Related Cognitions Scale (GRCS-I).

Authors:  Paolo Iliceto; Emanuele Fino; Camillo Cammarota; Eleni Giovani; Francesca Petrucci; Marta Desimoni; Ugo Sabatello; Gabriella Candilera; Tian Po Oei
Journal:  J Gambl Stud       Date:  2015-03

2.  APOE e4 genotype and cigarette smoking in adults with normal cognition and mild cognitive impairment: a retrospective baseline analysis of a national dataset.

Authors:  Raj K Kalapatapu; Kevin L Delucchi
Journal:  Am J Drug Alcohol Abuse       Date:  2013-06-28       Impact factor: 3.829

3.  Default mode network deactivation to smoking cue relative to food cue predicts treatment outcome in nicotine use disorder.

Authors:  Claire E Wilcox; Eric D Claus; Vince D Calhoun; Srinivas Rachakonda; Rae A Littlewood; Jessica Mickey; Pamela B Arenella; Natalie Goodreau; Kent E Hutchison
Journal:  Addict Biol       Date:  2017-02-23       Impact factor: 4.280

4.  Factors associated with smoking cessation.

Authors:  Samires Avelino de Souza França; Ana Ligian Feitosa das Neves; Tatiane Andressa Santos de Souza; Nandara Celana Negreiros Martins; Saul Rassy Carneiro; Edilene do Socorro Nascimento Falcão Sarges; Maria de Fátima Amine Houat de Souza
Journal:  Rev Saude Publica       Date:  2015-02-27       Impact factor: 2.106

5.  Service and sales workers, are they vulnerable to smoking cessation?

Authors:  Youn-Mo Cho; Jun-Pyo Myong; Hyoung-Ryoul Kim; HyeEun Lee; Jung-Wan Koo
Journal:  Ind Health       Date:  2017-06-20       Impact factor: 2.179

6.  Impact of Referral Sources and Waiting Times on the Failure to Quit Smoking: One-Year Follow-Up of an Italian Cohort Admitted to a Smoking Cessation Service.

Authors:  Lucia Borsari; Simone Storani; Carlotta Malagoli; Tommaso Filippini; Marco Tamelli; Marcella Malavolti; Fausto Nicolini; Marco Vinceti
Journal:  Int J Environ Res Public Health       Date:  2018-06-11       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.